Our findings demonstrate that the co-administration of OXA and E. coli effectively eradicates the tumors in the syngeneic mouse models through several mechanisms, including the DSP that disfavors the cancer growth, the activation of both the innate and adaptive immune systems, and the alleviation of the drug resistance. Here, DSP is linked to cancer.